Johnson & Johnson Share Price Buenos Aires S.E.
Equities
DJNJ3D
ARDEUT112687
Pharmaceuticals
Sales 2024 * | 88.35B 78,984B 6,921B | Sales 2025 * | 90.76B 81,141B 7,110B | Capitalization | 354B 316,216B 27,708B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 19,703B 1,726B | Net income 2025 * | 23.09B 20,644B 1,809B | EV / Sales 2024 * | 3.92 x |
Net cash position 2024 * | 7B 6,255B 548B | Net cash position 2025 * | 19.84B 17,739B 1,554B | EV / Sales 2025 * | 3.68 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
15.4
x | Employees | 131,900 |
Yield 2024 * |
3.28% | Yield 2025 * |
3.43% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 31/12/88 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 31/12/97 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 04/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 24/04/19 |
D. Davis
BRD | Director/Board Member | 72 | 18/06/14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 21/10/09 |
Date | Price | Change | Volume |
---|---|---|---|
27/05/24 | 1,250 | -.--% | 9 |
23/05/24 | 1,250 | -.--% | 11 |
End-of-day quote Buenos Aires S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+37.47% | 727B | |
+15.60% | 328B | |
-0.44% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.86% | 164B | |
-2.00% | 164B | |
-1.31% | 122B |